Markets
Medpace Revenue Rises 8.5% as Backlog Tops $3.1B
Medpace Q3 revenue rose 8.5% to $716 million as net income climbed 23.8%, backlog reached $3.17 billion and 2026 guidance increased.
Contract ResearchTag: Contract Research
Medpace Q3 revenue rose 8.5% to $716 million as net income climbed 23.8%, backlog reached $3.17 billion and 2026 guidance increased.